yeztugo lenacapavir - Search News

News

Lenacapavir becomes first FDA-approved HIV preventive drug

6 things to know about lenacapavir, what experts call a ‘wonder drug’ for preventing HIV

The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts say lenacapavir is easier to administer, and each dose lasts longer compared to other medications.

Wired · 12h

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.

CBS News on MSN · 1d

HIV prevention drug lenacapavir approved by FDA as twice-yearly injection

Clinical trials showed 99.9% of participants who received the drug, called Yeztugo from company Gilead Sciences, remained HIV negative.

Audacy on MSN36m

There's a new, highly effective HIV drug on the market

A revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...

MPR7h

Twice-Yearly HIV-1 PrEP Yeztugo Gets FDA Approval

Yeztugo (lenacapavir) is an HIV-1 capsid inhibitor that is administered every 6 months after an initial dosing regimen.

Managed Healthcare Executive1d

Lenacapavir HIV PrEP: Not an AIDS Vaccine, but Vaccine Adjacent

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results